Absynth Biologics Overview

  • Founded
  • 2006
Founded
  • Status
  • Out of Business
  • Employees
  • 11
Employees
  • Latest Deal Type
  • Out of Business

Absynth Biologics General Information

Description

Developer of innovative vaccines designed to prevent bacterial infections. The company's vaccines target staphylococcus aureus and clostridium difficile, which e causes of severe damage to health and can lead to death, enabling healthcare providers to develop the immunity system of their patients.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • BioHub at Alderley Park
  • Alderley Edge
  • Cheshire SK10 4TG
  • England, United Kingdom
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Absynth Biologics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Out of Business 01-Jan-2019 00.000 Completed Out of Business
9. Equity Crowdfunding 20-Sep-2017 00000 00.000 Completed Generating Revenue
8. Later Stage VC 30-Nov-2015 00.00 Cancelled Generating Revenue
7. Later Stage VC 30-Nov-2015 00000 00.000 Completed Generating Revenue
6. Later Stage VC 24-Jul-2014 00.00 00.000 00.000 Completed Generating Revenue
5. Grant 31-Jul-2013 00.000 00.000 Completed Generating Revenue
4. Later Stage VC 10-Jul-2013 00.00 00.000 00.000 Completed Generating Revenue
3. Grant 01-Jan-2012 00000 00000 Completed Startup
2. Early Stage VC 31-Jul-2007 $285K $836K Completed Startup
1. Early Stage VC $551K $551K Completed Startup
To view Absynth Biologics’s complete valuation and funding history, request access »

Absynth Biologics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary B 00 00.000000 000000.00 000000.00 00 000000.00 00.000
Ordinary A 00 00.000000 000000.00 000000.00 00 000000.00 00.000
To view Absynth Biologics’s complete cap table history, request access »

Absynth Biologics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial